SCHEMBL9199780

SCHEMBL9199780

CCC1CCCCN1C(=O)CCc1c(-c2ccccc2)nn2ccccc12

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.54
RAB9A P51151 3/20 0.54
MEN1 O00255 1/20 0.54
KMT2A Q03164 1/20 0.54
ADORA2A P29274 2/20 0.51
ADORA2B P29275 2/20 0.51
ADORA3 P0DMS8 1/20 0.51
ADORA1 P30542 1/20 0.51
HPGD P15428 3/20 0.50
L3MBTL1 Q9Y468 2/20 0.48
LMNA P02545 1/20 0.48
DAGLA Q9Y4D2 3/20 0.47
TP53 P04637 1/20 0.46
POLB P06746 1/20 0.45
ALDH1A1 P00352 2/20 0.42
KDM4E B2RXH2 2/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
HSD17B10 Q99714 1/20 0.42
ABHD11 Q8NFV4 1/20 0.42
EGFR P00533 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9198531 0.82 L3MBTL1 (0.62) NPC1RAB9AMEN1KMT2AADORA2A
SCHEMBL9199141 0.78 ADORA2A (0.81) NPC1RAB9AMEN1KMT2AADORA2A
SCHEMBL9199707 0.78 ADORA2A (0.57) NPC1RAB9AMEN1KMT2AADORA2A
SCHEMBL9199713 0.78 ADORA2A (0.57) NPC1RAB9AMEN1KMT2AADORA2A
SCHEMBL9199652 0.78 ADORA2A (0.81) NPC1RAB9AMEN1KMT2AADORA2A
SCHEMBL9199656 0.78 ADORA2A (0.81) NPC1RAB9AMEN1KMT2AADORA2A
SCHEMBL9199146 0.78 ADORA2A (0.81) NPC1RAB9AMEN1KMT2AADORA2A
SCHEMBL9193576 0.78 ADORA2A (0.81) NPC1RAB9AMEN1KMT2AADORA2A
SCHEMBL9193574 0.78 ADORA2A (0.81) NPC1RAB9AMEN1KMT2AADORA2A
SCHEMBL9200028 0.78 ADORA2A (0.51) NPC1RAB9AMEN1KMT2AADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0299209-B1 Pyrazolopyridine compound and processes for preparation thereof FUJISAWA PHARMACEUTICAL CO (JP) 1995-09-13 EP disclosed
US-5296490-A Pharmaceutically useful pyrazolopyridines FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1994-03-22 US disclosed
US-5087629-A Diuretics, hypotensive agents; cardiotonic agents FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1992-02-11 US disclosed
US-4994453-A Treating asthma, diabetes, obesity, immunosuppression FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1991-02-19 US disclosed
US-4925849-A DIURETICS, HYPOTENSIVE AGENTS, CARIOTONIC AGENTS AND ANTIEDEMIC AGENTS FUJISAWA PHARMACEUTICAL COMPANY, LTD. (JP) 1990-05-15 US disclosed
EP-0299209-A2 Pyrazolopyridine compound and processes for preparation thereof FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1989-01-18 EP disclosed